GLUCOPHAGE XR 1000 MG

Երկիր: Իսրայել

Լեզու: անգլերեն

Աղբյուրը: Ministry of Health

Ակտիվ բաղադրիչ:

METFORMIN HYDROCHLORIDE

Հասանելի է:

MERCK SERONO LTD

ATC կոդը:

A10BA02

Դեղագործական ձեւ:

TABLETS PROLONGED RELEASE

Կազմը:

METFORMIN HYDROCHLORIDE 1000 MG

Կառավարման երթուղին:

PER OS

Ռեկվիզորի տեսակը:

Required

Պատրաստված է:

MERCK SANTÉ S.A.S, FRANCE

Թերապեւտիկ տարածք:

METFORMIN

Թերապեւտիկ ցուցումներ:

• Reduction in the risk or delay of the onset of type 2 diabetes mellitus in adult, overweight patients with IGT* and/or IFG*, and/or increased HbA1C who are:- at high risk for developing overt type 2 diabetes mellitus and- still progressing towards type 2 diabetes mellitus despite implementation of intensive lifestyle change for 3 to 6 monthsTreatment with Glucophage XR must be based on a risk score incorporating appropriate measures of glycaemic control and including evidence of high cardiovascular risk.Lifestyle modifications should be continued when metformin is initiated, unless the patient is unable to do so because of medical reasons.*IGT: Impaired Glucose Tolerance; IFG: Impaired Fasting Glucose• Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Glucophage XR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Հաստատման ամսաթիվը:

2023-08-20